Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin McDonnell

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Annals of Neurology|September 27, 2002
Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosisIraide Alloza, Shirley Heggarty, An Goris, et al.
Ophthalmology Science|May 22, 2023
Reduced Cone Density Is Associated with Multiple SclerosisGemma McIlwaine, Lajos Csincsik, Rachel Coey, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 20, 2006
Outbreak of shigellosis in Irish holidaymakers associated with travel to EgyptPaul McKeown, Maire O'Connor, Gavin McDonnell, et al.
Journal of the Neurological Sciences|February 17, 2025
Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectoriesCarolyn A Young, David Rog, Basil Sharrack, et al.
Multiple Sclerosis and Related Disorders|November 23, 2024
Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialtyTarunya Arun, Kate Petheram, Emma Tallantyre, et al.
Annals of Neurology|October 27, 2018
Meningeal inflammation and cortical demyelination in acute multiple sclerosisRyan J Bevan, Rhian Evans, Lauren Griffiths, et al.
Journal of Neuroinflammation|November 23, 2020
CCN3 is dynamically regulated by treatment and disease state in multiple sclerosisMichelle Naughton, Jill Moffat, George Eleftheriadis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 30, 2011
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase RegistryStella Hughes, Timothy Spelman, Maria Trojano, et al.
JAMA Neurology|June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Stella Hughes, Gavin McDonnell, et al.
American Journal of Human Genetics|March 7, 2020
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain CalcificationLucia V Schottlaender, Rosella Abeti, Zane Jaunmuktane, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annals of Neurology|September 27, 2002
Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosisIraide Alloza, Shirley Heggarty, An Goris, et al.
Ophthalmology Science|May 22, 2023
Reduced Cone Density Is Associated with Multiple SclerosisGemma McIlwaine, Lajos Csincsik, Rachel Coey, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 20, 2006
Outbreak of shigellosis in Irish holidaymakers associated with travel to EgyptPaul McKeown, Maire O'Connor, Gavin McDonnell, et al.
Journal of the Neurological Sciences|February 17, 2025
Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectoriesCarolyn A Young, David Rog, Basil Sharrack, et al.
Multiple Sclerosis and Related Disorders|November 23, 2024
Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialtyTarunya Arun, Kate Petheram, Emma Tallantyre, et al.
Annals of Neurology|October 27, 2018
Meningeal inflammation and cortical demyelination in acute multiple sclerosisRyan J Bevan, Rhian Evans, Lauren Griffiths, et al.
Journal of Neuroinflammation|November 23, 2020
CCN3 is dynamically regulated by treatment and disease state in multiple sclerosisMichelle Naughton, Jill Moffat, George Eleftheriadis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 30, 2011
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase RegistryStella Hughes, Timothy Spelman, Maria Trojano, et al.
JAMA Neurology|June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Stella Hughes, Gavin McDonnell, et al.
American Journal of Human Genetics|March 7, 2020
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain CalcificationLucia V Schottlaender, Rosella Abeti, Zane Jaunmuktane, et al.
Pageof 3